| P50 | author | Angela Tincani | Q73304219 |
| P2093 | author name string | Laura Andreoli | |
| P2860 | cites work | Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals | Q28217805 |
| | Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) | Q28284893 |
| | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 |
| | Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers | Q36843689 |
| | Hughes syndrome (the antiphospholipid syndrome): 25 years old. | Q37101366 |
| | Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms | Q37249524 |
| | Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases). | Q46508618 |
| | Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No. | Q46521769 |
| | Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers | Q46574638 |
| | Invitation to a debate on the serological criteria that define the antiphospholipid syndrome | Q48034591 |
| | Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis | Q48394757 |
| | Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry | Q71112355 |
| | Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men | Q72369034 |
| | New approaches to prevention of thrombosis in the antiphospholipid syndrome: Hopes, trials, and tribulations | Q79288146 |
| | Antiphospholipid syndrome dilemmas still to be solved: 2008 status | Q80894085 |
| | Risk factors for a first thrombotic event in antiphospholipid antibody carriers. A multicentre, retrospective follow-up study | Q82045296 |
| P433 | issue | 2 | |
| P921 | main subject | antiphospholipid syndrome | Q582207 |
| P304 | page(s) | 165-167 | |
| P577 | publication date | 2009-01-08 | |
| P1433 | published in | Internal and emergency medicine | Q26842320 |
| P1476 | title | 25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies | |
| P478 | volume | 4 | |